TG Therapeutics
Michele Kosnik is an experienced sales professional with a strong background in the pharmaceutical and biotech industries. Currently serving as Associate Director of Key Accounts at TG Therapeutics, Inc. since April 2023, Michele previously worked as a Neurology Sales Representative at Bristol-Myers Squibb from February 2020 to April 2023. Prior roles include Cardiovascular Specialty Representative at IQVIA/Janssen, where anticoagulants for stroke prevention were promoted, and Pharmaceutical Sales Representative II at Boehringer Ingelheim, focusing on respiratory, diabetes, and cardiovascular products. Additionally, Michele has experience as a Biotech Sales Representative at Alkermes/Cephalon, specializing in injectables for opioid addiction, and served as a Senior Product Specialist in Biotech at Ortho Biotech (Johnson & Johnson), concentrating on treatments for anemia associated with chronic kidney disease. Michele holds a BA in Business Administration with a focus on Marketing and Sales from Cal State Fullerton, completed between 1995 and 1997, and also attended Hawaii Pacific University from 1998 to 1999.
This person is not in any teams
This person is not in any offices
TG Therapeutics
2 followers
TG Therapeutics is a fully-integrated, commercial-stage biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases.